Primary Record
Beloranib
- In stock
- 9,588 g
- Purity
- 98.3 %
- CAS
- 251111-30-5
Compound Identifiers & Properties
- CAS
- 251111-30-5
- PubChem CID
- 6918502
- SMILES
- CC(=CC[C@@H]1[C@@](O1)(C)[C@H]2[C@@H]([C@@H](CC[C@]23CO3)OC(=O)/C=C/C4=CC=C(C=C4)OCCN(C)C)OC)C
- Canonical SMILES
- CO[C@@H]1[C@H](OC(=O)/C=C/c2ccc(OCCN(C)C)cc2)CC[C@]2(CO2)[C@H]1[C@@]1(C)O[C@@H]1CC=C(C)C
Names & Synonyms
- Beloranib
- Beloranib [INN]
- beloranibum
- 251111-30-5
- ZGN-433
- ZGN-440
- AC1OCFID
- Beloranib (>85%)
- CKD-732
- ZGN-440(Beloranib)
- BELORANIB [WHO-DD]
- RefChem:561223
- ZGN 440
- Ckd732
- FI471K8BU6
- UNII-FI471K8BU6
- D0E4VQ
- D0WI4R
- DTXSID40179800
- ZGN 433
- GTPL8445
- orb1705928
- US9682965, Compound A
- CHEMBL4297504
- SCHEMBL14648763
- CKD-731
- DTXCID60102291
- HRK-429
- HRK-512
- CHEBI:230921
- ZEZFKUBILQRZCK-MJSCXXSSSA-N
- BDBM148430
- ZGN-440;CDK-732
- Fumagillin analogs, Chong Kun Dang
- ZINC3982162
- AKOS027326543
- CID6918502
- DB12671
- FB61548
- O-[4-(2-Dimethylaminoethoxy)-trans-cinnamoyl]fumagillol
- HY-14811
- O-(4-(2-Dimethylaminoethoxy)-trans-cinnamoyl)fumagillol
- O-(4-Dimethylaminoethoxycinnamoyl)fumagillol
- CS-0003572
- FT-0699345
- NS00069712
- J2.308.836C
- J3.728.315K
- A13870
- (3R,4S,5S,6R)-5-Methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-yl (2E)-3-(4-(2-(dimethylamino)ethoxy)phenyl)prop-2-enoate
- Q4884554
- [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-[2-(dimethylamino)ethoxy]phenyl]prop-2-enoate
- (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (2E)-3-{4-[2-(dimethylamino)ethoxy]phenyl}prop-2-enoate
- (2E)-3-{3-[(dimethylamino)methyl]-4-methoxyphenyl}acrylic acid
- [(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] (E)-3-[4-(2-dimethylaminoethoxy)phenyl]prop-2-enoate
- ((3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-yl) (E)-3-(4-(2-dimethylaminoethoxy)phenyl)prop-2-enoate
- (3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl)-1-oxaspiro(2.5)oct-6-yl (2E)-3-(4-(2-(dimethylamino)ethoxy)phenyl)acrylate
- (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl 3-{4-[2-(dimethylamino)ethoxy]phenyl}prop-2-enoate
- [(3R,6R,7S,8S)-7-methoxy-8-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-2-oxaspiro[2.5]octan-6-yl] (E)-3-[4-(2-dimethylaminoethyloxy)phenyl]prop-2-enoate
- 2-Propenoic acid, 3-[4-[2-(dimethylamino)ethoxy]phenyl]-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester, (2E)-
- 251111-38-3
- 3-[4-[2-(Dimethylamino)ethoxy]phenyl]acrylic acid (3R)-4beta-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-5alpha-methoxy-1-oxaspiro[2.5]octane-6alpha-yl ester
- 4-[2-(Dimethylamino)ethoxy]-trans-cinnamic acid (3R,4S)-4beta-[(2R)-2-methyl-3beta-prenyloxirane-2alpha-yl]-5alpha-methoxy-1-oxaspiro[2.5]octane-6alpha-yl ester
- 609845-93-4